☆ 4.7 Article

A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus

VACCINES (2023)

Related references

Note: Only part of the references are listed.

Article Biotechnology & Applied Microbiology

A novel plant-made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS-CoV-2 Omicron variant

Collin Jugler et al.

Summary: This study describes the discovery of a new, neutralizing monoclonal antibody (mAb), 11D7, against the Wuhan-Hu-1 RBD of SARS-CoV-2. The mAb was developed into a chimeric human IgG and expressed in plants to produce a mAb with human-like glycan structure, potentially increasing its therapeutic potency and safety. 11D7 recognizes and neutralizes the Omicron variant and may provide additional synergy when used in combination with established antibody cocktails.

PLANT BIOTECHNOLOGY JOURNAL (2023)

Add to Collection

Article Immunology

Antibody-Dependent Enhancement Activity of a Plant-Made Vaccine against West Nile Virus

Haiyan Sun et al.

Summary: Researchers have developed a plant-based vaccine candidate that provides protective immunity against lethal West Nile virus and minimizes the risk of infection by Zika and dengue viruses.

VACCINES (2023)

Add to Collection

Review Multidisciplinary Sciences

In vitro and in vivo models for monkeypox

Rafael Borges Rosa et al.

Summary: The emergence and rapid spread of monkeypox virus (MPXV) outside of endemic areas during the COVID-19 pandemic has created a global health emergency. Scientists have been working on developing in vitro and in vivo models for MPXV research. In vitro models, including 2D and 3D cultures, are cost-effective and can be controlled, but may not fully represent physiological conditions. Therefore, in vivo models are being characterized to meet the demand for studying MPXV. This review summarizes the existing MPXV models and discusses their contributions to understanding pathogenesis, replication, transmission, and antiviral treatment.

ISCIENCE (2023)

Add to Collection

Review Microbiology

SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies

MacGregor Cox et al.

Summary: Monoclonal antibodies (mAbs) are an important treatment option for severe COVID-19, but the emergence of new SARS-CoV-2 variants has led to evasion of mAb-induced protection. Spike protein amino acid substitutions, both at epitope and non-epitope positions, play a role in resistance to mAb neutralization. Understanding the dynamics of viral evasion can inform surveillance and the development of novel mAb therapies.

NATURE REVIEWS MICROBIOLOGY (2023)

Add to Collection

Article Virology

A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics

Haiyan Sun et al.

Summary: This study demonstrates a two-tier approach for eliminating antibody-dependent enhancement (ADE) while preserving Fc effector functions in the treatment of Dengue virus and Zika virus infections. The selection of virus/serotype-specific antibodies and modulation of Fc glycosylation can effectively prevent ADE. The findings suggest that glycovariants with modified Fc glycans can abrogate ADE and retain antibody-dependent cellular cytotoxicity.

VIRUSES-BASEL (2023)

Add to Collection

Article Immunology

Plant-Produced Anti-Zika Virus Monoclonal Antibody Glycovariant Exhibits Abrogated Antibody-Dependent Enhancement of Infection

Ming Yang et al.

Summary: Monoclonal antibodies have great potential as therapeutics against Zika virus, but may enhance infection by dengue virus. This study demonstrates the possibility of reducing the risk of dengue virus infection by modifying antibody glycosylation.

VACCINES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus

Ye Sang et al.

Summary: Monkeypox has been declared a public health emergency by the World Health Organization. Two mRNA vaccines, mRNA-A-LNP and mRNA-B-LNP, based on specific proteins of the monkeypox virus, have been developed and shown to induce immune responses in mice, including specific antibodies and cellular immunity. These vaccines also provide protection against vaccinia virus challenge in mice and have the potential to be used against other orthopoxviruses.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Add to Collection

Review Immunology

Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection

Ali Zhang et al.

Summary: Neutralizing antibodies play a crucial role in protecting against SARS-CoV-2 infection and have been suggested as a useful indicator for vaccine trials and population surveys. Besides directly neutralizing the virus, antibodies can also interact with immune cells and complement through their Fc domains. The outcome of these interactions depends on various factors, including antibody isotype-Fc receptor combinations and post-translational modifications. Understanding the roles of Fc-dependent antibody effector functions in SARS-CoV-2 infection has implications for the development of future vaccines and therapeutics.

NATURE REVIEWS IMMUNOLOGY (2023)

Add to Collection

Review Virology

Development of plant-made monoclonal antibodies viral infections

Qiang Chen

Summary: Current plant-based systems offer multiple advantages for monoclonal antibody development and production, including rapid and efficient manufacturing and unique glycoform expression. This review summarizes the progress of anti-viral antibody development using plant-based systems and discusses the challenges and potential applications of plant-based genome technologies.

CURRENT OPINION IN VIROLOGY (2022)

Add to Collection

Review Immunology

Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters

Yan Xiang et al.

Summary: Monkeypox virus is a closely related virus to smallpox virus, causing a milder febrile rash illness in humans. While it used to be a rare zoonotic disease confined to forested areas in West and Central Africa, the number of cases and geographical range have significantly increased in recent years. The outbreak of monkeypox since May 2022 in multiple countries, with a large number of cases and no direct links to endemic areas, raises concerns about a possible change in transmission pattern and a greater global threat. This review highlights recent progress in understanding the virus host range, evolutionary potential, and neutralization targets for risk assessment and preparedness for a monkeypox epidemic.

EMERGING MICROBES & INFECTIONS (2022)

Add to Collection

Review Immunology

Vaccination for Monkeypox Virus Infection in Humans: A Review of Key Considerations

Kay Choong See

Summary: Monkeypox virus infection in humans is a global public health concern, with over 3000 reported cases in more than 50 countries. Adults generally have mild disease, while poorer outcomes are observed in children, immunocompromised patients, and pregnant women. The risk-benefit profile of monkeypox-specific treatments is unclear, but two effective vaccines exist for prevention. Vaccination is likely to be a key strategy for mitigating the spread of monkeypox, with priority given to healthcare workers, immunocompromised patients, and children.

VACCINES (2022)

Add to Collection

Article Immunology

SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody

Collin Jugler et al.

Summary: This study investigated the feasibility of producing an anti-IL-6 receptor monoclonal antibody in plants and its potential utility in reducing IL-6 signaling during SARS-CoV-2 infection. The plant-produced anti-IL-6 receptor monoclonal antibody was shown to effectively inhibit IL-6 signaling, suggesting its promising role in curbing cytokine storm in COVID-19 patients.

VACCINES (2021)

Add to Collection

Review Immunology

Neutralizing monoclonal antibodies for treatment of COVID-19

Peter C. Taylor et al.

Summary: The study discusses the clinical utility of neutralizing monoclonal antibody therapies targeting SARS-CoV-2, emphasizing the importance of patient stratification, biomarkers, risk factors, and other clinical considerations.

NATURE REVIEWS IMMUNOLOGY (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Co-expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants

Emmanuel Margolin et al.

PLANT BIOTECHNOLOGY JOURNAL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Hydrophobin-Protein A Fusion Protein Produced in Plants Efficiently Purified an Anti-West Nile Virus Monoclonal Antibody from Plant Extracts via Aqueous Two-Phase Separation

Collin Jugler et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Chemistry, Applied

N-Glycosylation of IgG and IgG-Like Recombinant Therapeutic Proteins: Why Is It Important and How Can We Control It?

Natalia I. Majewska et al.

ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 11 (2020)

Add to Collection

Article Plant Sciences

Production of Biopharmaceuticals in Nicotiana benthamiana-Axillary Stem Growth as a Key Determinant of Total Protein Yield

Marie-Claire Goulet et al.

FRONTIERS IN PLANT SCIENCE (2019)

Add to Collection

Article Medicine, Research & Experimental

The less-is-more in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity

Natasha A. Pereira et al.

MABS (2018)

Add to Collection

Review Plant Sciences

The Rise and Rise of Nicotiana benthamiana: A Plant for All Reasons

Julia Bally et al.

ANNUAL REVIEW OF PHYTOPATHOLOGY, VOL 56 (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

N-glycan engineering of a plant-produced anti-CD20-hIL-2 immunocytokine significantly enhances its effector functions

Carla Marusic et al.

BIOTECHNOLOGY AND BIOENGINEERING (2018)

Add to Collection

Review Immunology

Beyond binding: antibody effector functions in infectious diseases

Lenette L. Lu et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Add to Collection

Review Rheumatology

Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Michaela Seeling et al.

NATURE REVIEWS RHEUMATOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems - The taliglucerase alfa story

Bonita Rup et al.

PLOS ONE (2017)

Add to Collection

Article Medicine, Research & Experimental

Techno-economic analysis of a transient plant-based platform for monoclonal antibody production

Somen Nandi et al.

MABS (2016)

Add to Collection

Letter Biotechnology & Applied Microbiology

Plant specific N-glycans do not have proven adverse effects in humans

Yoseph Shaaltiel et al.

NATURE BIOTECHNOLOGY (2016)

Add to Collection

Editorial Material Multidisciplinary Sciences

Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms

Qiang Chen

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Add to Collection

Article Biochemical Research Methods

Purification of monoclonal antibody against Ebola GP1 protein expressed in Nicotiana benthamiana

Andrew Fulton et al.

JOURNAL OF CHROMATOGRAPHY A (2015)

Add to Collection

Article Multidisciplinary Sciences

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

Xiangguo Qiu et al.

NATURE (2014)

Add to Collection

Article Immunology

Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo

Jeffrey R. Kugelman et al.

EMERGING INFECTIOUS DISEASES (2014)

Add to Collection

Article Multidisciplinary Sciences

Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors

Matthew E. Cohen et al.

PLOS ONE (2011)

Add to Collection

Article Virology

Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease

Joseph W. Golden et al.

VIROLOGY JOURNAL (2011)

Add to Collection

Article Multidisciplinary Sciences

Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo

Anne W. Rimoin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Add to Collection

Article Virology

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine

Mohammed Rafii-El-Idrissi Benhnia et al.

JOURNAL OF VIROLOGY (2008)

Add to Collection

Article Virology

Vaccinia virus L1 protein is required for cell entry and membrane fusion

Himani Bisht et al.

JOURNAL OF VIROLOGY (2008)

Add to Collection

Article Virology

Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein

Hua-Poo Su et al.

VIROLOGY (2007)

Add to Collection

Article Virology

Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge

S Lustig et al.

JOURNAL OF VIROLOGY (2005)

Add to Collection

Article Biochemistry & Molecular Biology

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

Y Edghill-Smith et al.

NATURE MEDICINE (2005)

Add to Collection

Article Multidisciplinary Sciences

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

IM Belyakov et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Add to Collection

Article Virology

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

JW Hooper et al.

VIROLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.